Status:
RECRUITING
Journey Bicruciate Stabilized (BCS) Design and Legion Posterior Stabilized (PS) Design; Comparative Study
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Primary Total Knee Arthroplasty
Eligibility:
All Genders
55-75 years
Phase:
NA
Brief Summary
Today, primary total knee arthroplasty (TKA) is considered to be a safe and successful therapy for end-stage osteoarthritis of the knee. In the past decades, different total knee prostheses have been ...
Detailed Description
Today, primary total knee arthroplasty (TKA) is considered to be a safe and successful therapy for end-stage osteoarthritis of the knee. In the past decades, different total knee prostheses have been ...
Eligibility Criteria
Inclusion
- ICF obtained
- End stage bi- or tricompartmental osteoarthritis of the knee meeting the general criteria for TKA
Exclusion
- Inflammatory arthritis (e.g. rheumatoid arthritis).
- BMI \>30 due to less accurate gait analysis.
- Extension deficit of \>10° and flexion deficit of \<110° of the knee.
- Varus and valgus deviations \>10° of the knee
- Mental retardation, a systemic disease or decline normal health causing post-operative rehabilitation cannot take place properly.
- Suggestive musculoskeletal deformity of the lower limb or vertebral column, causing postoperative rehabilitation cannot take place properly to prevent confounding. Normal joints are defined as asymptomatic joints with normal physical examination and mild to no changes on radiographs. An exception is made for primary total hip prosthesis.
Key Trial Info
Start Date :
August 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04855864
Start Date
August 8 2023
End Date
December 1 2025
Last Update
November 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000